Samsung Biologics with KRW 464.6 billion sales

Samsung Biologics achieved KRW 464.6 billion sales last year based on the March audit report, growing 57.7% up compared to the same period of time year before.

They turned operating profits from deficits to KRW 60 billion surpluses, and continued to make KRW 97 billion deficits compared to the same period of time.

They also spent KRW 65.8 billion SG&A(selling, general & administrative) expens...